Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04291859 · ClinicalTrials.gov registry record · Phase 1

Lu AF28996 in Participants With Parkinson's Disease (PD)

A Phase 1 study of Parkinson Disease, sponsored by H. Lundbeck A/S.

Completed
Registry status
Phase 1
Development phase
57
Enrollment target
15
Study locations

NCT04291859 is a Phase 1 study of Parkinson Disease that has completed, run by H. Lundbeck A/S. The registered enrollment target is 57 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 15 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04291859, a Phase 1 study of Parkinson Disease, has completed, sponsored by H. Lundbeck A/S.

COMPLETED
Registry status
Phase 1
Development phase
57 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.

Conditions Studied

Parkinson Disease

Interventions

  • DRUG Lu AF28996

Study Locations (15)

Other

  • Curiositas-ad-sanum - Hamburg
  • QPS Netherlands BV - Leeuwarden
  • Hospital Vall d´Hebron - Barcelona
  • Hosp. General Catalunya - Mira-Sol
  • Virgen Del Roccio - Seville

Florida

  • Velocity - Hallandale
  • Parkinson's Disease Treatment Center of SW FL - Port Charlotte

California

  • CenExel Los Alamitos - Los Alamitos

District of Columbia

  • Georgetown University - Washington D.C.

Georgia

  • Atlanta Center for Medical Research - Atlanta

Hawaii

  • Hawaii Pacific Neuroscience - Honolulu

Michigan

  • QUEST Research Institute - Farmington Hills

Nebraska

  • Neurology Consultants of Nebraska - Omaha

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2020-02-26
Est. Completion 2026-02-12
Phase Phase 1

Sponsor

H. Lundbeck A/S

72 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04291859

The ClinicalTrials.gov registry entry for NCT04291859 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Lu AF28996 is the first listed.

NCT04291859 reports 15 study locations spanning 10 distinct geographic areas - top geographies include Other, Florida, California.

Frequently Asked Questions

What is clinical trial NCT04291859 about?

NCT04291859 is a clinical study titled "Lu AF28996 in Participants With Parkinson's Disease (PD)". The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.

What is the current status of trial NCT04291859?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 57 participants. The study started on 2020-02-26. Estimated completion is 2026-02-12.

What conditions does trial NCT04291859 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT04291859?

The interventions under investigation include: Lu AF28996 (DRUG).

Who is sponsoring clinical trial NCT04291859?

This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04291859 being conducted?

This trial has 15 study locations across California, District of Columbia, Florida, Georgia, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.